DSpace logo

Search


Start a new search
Add filters:

Use filters to refine the search results.


Results 12651-12660 of 15516 (Search time: 0.013 seconds).
Item hits:
Issue DateTitleAuthor(s)
2016-055HT3 receptors: Target for new antidepressant drugsMahesh, R.
2011-04Citric acid: An efficient and green catalyst for rapid one pot synthesis of quinoxaline derivatives at room temperatureMahesh, R.
2014-07Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent modelsMahesh, R.
2015-01QCM-4, a 5-HT3 receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese miceMahesh, R.
2015-09Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmissionMahesh, R.
2014-06Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery testsMahesh, R.
2010-11Design, synthesis and structure–activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depressionMahesh, R.
2014-08Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomyMahesh, R.
2006-05Synthesis and biological evaluation of a novel structural type of serotonin 5-HT3 receptor antagonistsMahesh, R.
2017-12Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat modelMahesh, R.